Deletion of Id3 leads to increased PD-1 expression in Th1 cells, promoting their dysfunction, and reduces the number of tissue-infiltrating TCF1+ stem-like cells, ultimately inhibiting GVHD progression. Here, ID3 is linked to graft versus host disease.